What is Theravance Biopharma's taxes paid?

Theravance Biopharma (TBPH) reported taxes paid of -$351K in Q1 2026.

How has Theravance Biopharma's taxes paid changed year-over-year?

Theravance Biopharma's taxes paid decreased by 8875.0% year-over-year, from $4K to -$351K.

What is the long-term trend for Theravance Biopharma's taxes paid?

Over 2 years (2023 to 2025), Theravance Biopharma's taxes paid has grown at a 3308.6% compound annual growth rate (CAGR), from $24K to $27.88M.

What does taxes paid mean?

Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.

Theravance Biopharma TBPH Taxes Paid

Taxes Paid at other companies

United TherapeuticsUTHR

$1.5M+200%

Aurinia PharmaceuticalsAUPH

$1.33M+439%

Mirum Pharmaceuticals, Inc.MIRM

$220K+35.8%

Innoviva, Inc.INVA

$670K—

ALN

Alnylam PharmaceuticalsALNY

$2.37M-20.2%

XOMA CorporationXOMA

$277K—

Other financials

Income statement

See full

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$896.51M+68.7%

Enterprise value$648.91M+38.3%

P/E7.8×—

P/S8.2×0.0×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Reported directly by Theravance Biopharma in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Theravance Biopharma's taxes paid?: Theravance Biopharma (TBPH) reported taxes paid of -$351K in Q1 2026.
How has Theravance Biopharma's taxes paid changed year-over-year?: Theravance Biopharma's taxes paid decreased by 8875.0% year-over-year, from $4K to -$351K.
What is the long-term trend for Theravance Biopharma's taxes paid?: Over 2 years (2023 to 2025), Theravance Biopharma's taxes paid has grown at a 3308.6% compound annual growth rate (CAGR), from $24K to $27.88M.
What does taxes paid mean?: Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.